• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Synlogic, Inc. - Common Stock (NQ:SYBX)

0.5600 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Synlogic, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Halper Sadeh LLC is Investigating Whether BWMN, SUNS, DV, SYBX are Obtaining Fair Deals for their Shareholders
August 29, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Synlogic Reports Third Quarter 2024 Financial Results
November 12, 2024
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Reports Second Quarter 2024 Financial Results
August 08, 2024
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Reports First Quarter 2024 Financial Results
May 14, 2024
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
March 19, 2024
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Adopts Limited Duration Stockholders Rights Plan
February 20, 2024
Engages Ladenburg Thalmann as financial advisor to assist with previously announced strategic review process 
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
February 08, 2024
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
February 02, 2024
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Sidoti Events, LLC's Virtual January Micro-Cap Conference
January 15, 2024
Via ACCESSWIRE
News headline image
Synlogic Provides Corporate Update and Outlook for 2024
January 04, 2024
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Contract with the Air Force Research Lab
December 27, 2023
- Selection of Synlogic reflects Company’s leadership in process development and manufacturing of therapeutics based on synthetic biology - 
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023
December 07, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 09, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration
November 07, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Closing of $21.0 Million Underwritten Public Offering
October 03, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
September 29, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism
September 28, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Reverse Stock Split
September 27, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic to Participate in Chardan’s Genetic Medicines Conference
September 21, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100
September 19, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
Recent milestones include initiation of the pivotal Phase 3 trial, Synpheny-3, and receipt of Fast Track designation for labafenogene marselecobac as a potential treatment for PKU 
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria
July 11, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces International Nonproprietary Name Selection for SYNB1934
June 28, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum
June 27, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Reminds Stockholders of 2023 Annual General Meeting Details
June 08, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
June 05, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
May 24, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic to Present at the Jefferies Global Healthcare Conference
May 23, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From Synlogic, Inc.
Via GlobeNewswire
News headline image
Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of Phenylketonuria
May 09, 2023
From Synlogic, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap